Sysmex (SSMXY) Stock Price, News & Analysis

Company Overview

Sysmex Corporation is a Japan-based healthcare technology company that develops, manufactures and sells diagnostic instruments, reagents and related information systems. Its products are primarily used in clinical laboratories, hospitals and other healthcare settings to support the analysis of blood, urine and other biological samples.

The company is best known for its hematology testing systems, including automated analyzers used to assess blood cell counts and related parameters. Its portfolio also includes products for hemostasis and coagulation testing, urinalysis, clinical chemistry, immunochemistry and flow cytometry, as well as laboratory information systems, maintenance and other support services.

Sysmex was established in 1968 and is headquartered in Kobe, Japan. The company serves healthcare institutions and laboratory customers internationally through operations, subsidiaries and distribution networks spanning Japan and other markets in Asia, the Americas, Europe and additional regions. Its business combines recurring demand for diagnostic reagents and services with the sale and support of laboratory equipment.

Key Stats

• Today's Range: $11.72 to $12.11
• 50-Day Range: $9.15 to $12.58
• 52-Week Range: $8.01 to $12.90
• Volume: 30,710 shs
• Average Volume: 37,410 shs
• Market Capitalization: $7.43 billion
• P/E Ratio: 28.12
• Dividend Yield: 1.19%
• Price Target: N/A
• Consensus Rating: Hold

Sysmex Stock Analysis - MarketRank™

Sysmex scored higher than 49% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.4 / 5
• Analyst Rating: Hold

Consensus Rating

Sysmex has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on no strong buy ratings, 1 buy rating, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Sysmex has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 34.21%

Earnings Growth

Earnings for Sysmex are expected to grow by 34.21% in the coming year, from $0.38 to $0.51 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Sysmex is 28.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.95.

Price to Earnings Ratio vs. Sector

The P/E ratio of Sysmex is 28.12, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 275.79.

Price to Book Value per Share Ratio

Sysmex has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.04% of the float of Sysmex has been sold short.

Short Interest Ratio / Days to Cover

Sysmex has a short interest ratio ("days to cover") of 6.08.

Change versus previous month

Short interest in Sysmex has recently decreased by 2.87%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Sysmex pays a meaningful dividend of 1.16%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Sysmex does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Sysmex is 33.33%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Sysmex will have a dividend payout ratio of 27.45% next year. This indicates that Sysmex will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Sysmex this week, compared to 0 articles on an average week.

Company Ownership

• Score: N/A
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Sysmex insiders have not sold or bought any company stock.

Percentage Held by Institutions

Sysmex has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/07/2026
• Today: 9/19/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 3/31/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: OTCMKTS:SSMXY
• CIK: 1517231
• Web: www.sysmex.co.jp
• Phone: (178) 265-0500
• Fax: 817-8265-0524
• Employees: 11,457
• Year Founded: 1968

Profitability

• EPS (Trailing Twelve Months): $0.42
• Trailing P/E Ratio: 28.12
• Forward P/E Ratio: 31.08
• P/E Growth: N/A
• Net Income: $234.01 million
• Net Margins: 7.62%
• Pretax Margin: 9.81%
• Return on Equity: 8.01%
• Return on Assets: 5.61%

Debt

• Debt-to-Equity Ratio: 0.23
• Current Ratio: 3.40
• Quick Ratio: 2.53

Sales & Book Value

• Annual Sales: $3.32 billion
• Price / Sales: 2.24
• Cash Flow: $0.84 per share
• Price / Cash Flow: 13.99
• Book Value: $5.30 per share
• Price / Book: 2.23

Miscellaneous

• Outstanding Shares: 629,480,000
• Free Float: N/A
• Market Cap: $7.43 billion
• Optionable: Not Optionable
• Beta: 1.09